NAM
KYMR icon

NorthCrest Asset Manangement’s Kymera Therapeutics KYMR Stock Holding History

NorthCrest Asset Manangement’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$258K Buy
+2,357
New +$270K 0.01% 878

Other funds holding KYMR

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CIA
Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

NorthCrest Asset Manangement's KYMR Position: Q3 2026 in Review

NorthCrest Asset Manangement opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 2,357 shares worth $258K. The stake represents 0.01% of the portfolio and ranks #878 among its holdings.

7 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • NorthCrest Asset Manangement held 2,357 shares of Kymera Therapeutics worth $258K as of Q3 2026.
  • Kymera Therapeutics was a new NorthCrest Asset Manangement position in Q3 2026.
  • Kymera Therapeutics made up 0.01% of NorthCrest Asset Manangement's portfolio in Q3 2026, its #878 holding.
  • 7 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.